Stocks Telegraph

BPMC Stock Price History and Quote Analysis: Insights for Investors

NASDAQ:BPMC

Blueprint Medicines Corporation

$88.81
1.84+2.12%
At Close 4:00 PM
62.9
BESG ScoreESG Rating

BPMC FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

BPMC Income Statement


A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
revenue138.157M96.116M71.957M56.566M57.57M
cost of revenue11.21M8.001M1.791M4.553M2.323M
gross profit126.947M88.115M70.166M52.013M55.247M
gross profit ratio0.9190.9170.9750.920.96
research and development expenses80.653M83.381M96.006M110.252M110.063M
general and administrative expenses66.631M66.627M62.37M57.67M53.212M
selling and marketing expenses22.708M16.93M16.90M13.071M18.719M
selling general and administrative expenses89.339M83.557M79.27M70.741M71.931M
other expenses-1.00K376.00K-577.00K-728.00K-626.00K
operating expenses169.992M166.938M175.276M180.993M183.228M
cost and expenses181.202M174.939M177.067M185.546M185.551M
interest income9.936M9.178M9.834M9.329M7.749M
interest expense16.80M15.073M15.004M-3.808M-3.996M
depreciation and amortization3.617M4.81M1.531M2.872M3.578M
ebitda-39.428M-74.013M-103.579M-128.98M-127.981M
ebitda ratio-0.285-0.77-1.439-2.28-2.223
operating income-43.045M-78.823M-105.11M-128.98M-127.981M
operating income ratio-0.312-0.82-1.461-2.28-2.223
total other income expenses net-6.847M168.139M-5.747M-4.536M-626.00K
income before tax-49.892M89.316M-110.857M-133.516M-132.603M
income before tax ratio-0.3610.929-1.541-2.36-2.303
income tax expense102.00K180.00K61.00K197.00K190.00K
net income-49.994M89.136M-110.918M-133.713M-132.793M
net income ratio-0.3620.927-1.541-2.364-2.307
eps-0.801.45-1.82-2.20-2.19
eps diluted-0.801.40-1.82-2.20-2.19
weighted average shs out62.854M61.58M60.89M60.688M60.516M
weighted average shs out dil62.854M63.802M60.89M60.688M60.516M
Graph

BPMC Balance Sheet


Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
cash and cash equivalents54.771M113.326M71.286M55.972M75.527M
short term investments708.831M534.575M639.355M657.012M647.107M
cash and short term investments763.602M647.901M710.641M827.226M836.566M
net receivables85.058M60.047M43.178M41.254M38.267M
inventory14.789M30.94M21.223M16.457M17.016M
other current assets40.095M37.714M33.351M37.477M33.418M
total current assets903.544M776.602M808.393M808.172M811.335M
property plant equipment net109.048M113.169M115.65M115.84M114.486M
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments143.281M126.126M94.557M142.031M141.721M
tax assets00000
other non current assets47.687M22.578M30.65M39.256M38.903M
total non current assets300.016M261.873M240.857M297.127M295.11M
other assets1.0001.0000
total assets1.204B1.038B1.049B1.105B1.106B
account payables4.858M4.926M4.71M6.963M6.979M
short term debt114.658M87.149M81.409M41.838M29.149M
tax payables00000
deferred revenue3.748M7.251M812.00K448.157M445.669M
other current liabilities120.539M107.277M127.992M-299.574M-312.769M
total current liabilities243.803M206.603M214.923M197.384M169.028M
long term debt550.447M432.295M610.962M84.036M87.049M
deferred revenue non current8.041M4.635M4.792M5.00M5.00M
deferred tax liabilities non current75.244M78.489M81.751M00
other non current liabilities5.784M5.766M6.213M616.268M534.238M
total non current liabilities639.516M521.185M703.718M705.304M626.287M
other liabilities01.00000
capital lease obligations75.244M78.489M81.751M95.653M98.341M
total liabilities883.319M727.788M918.641M902.688M795.315M
preferred stock00000
common stock63.00K63.00K61.00K61.00K61.00K
retained earnings-2.301B-2.251B-2.34B-2.229B-2.095B
accumulated other comprehensive income loss-3.89M-3.847M-3.495M-2.683M-4.221M
other total stockholders equity2.625B2.565B2.474B2.434B2.411B
total stockholders equity320.241M310.687M130.609M202.611M311.13M
total equity320.241M310.687M130.609M202.611M311.13M
total liabilities and stockholders equity1.204B1.038B1.049B1.105B1.106B
minority interest00000
total investments852.112M660.701M733.912M657.012M647.107M
total debt740.349M597.933M774.122M125.874M116.198M
net debt685.578M484.607M702.836M69.902M40.671M
Graph

BPMC Cash Flow


A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax00-28.885M-11.527M0
stock based compensation28.022M24.225M22.585M23.07M23.821M
change in working capital-26.808M-43.203M10.404M2.972M-28.083M
accounts receivables-25.068M-17.339M-1.703M-5.865M-8.156M
inventory-4.686M2.696M829.00K2.917M-8.19M
accounts payables-82.00K313.00K-2.364M26.00K-3.588M
other working capital3.028M-28.873M13.642M5.894M-8.149M
other non cash items62.183M-128.306M26.355M11.844M3.003M
net cash provided by operating activities-48.072M-101.513M-78.928M-104.483M-130.475M
investments in property plant and equipment-2.569M-1.104M-4.673M-6.251M-2.554M
acquisitions net0003.335M-34.62M
purchases of investments-355.473M-200.165M-117.658M-240.935M-274.895M
sales maturities of investments169.75M278.40M201.10M237.60M309.515M
other investing activites078.235M0-3.335M34.62M
net cash used for investing activites-188.292M77.131M78.769M-9.586M32.066M
debt repayment-146.973M-369.00K-35.00K-97.968M0
common stock issued31.211M67.332M15.607M431.00K5.298M
common stock repurchased00000
dividends paid00000
other financing activites-172.00K-369.00K-44.00K195.936M5.298M
net cash used provided by financing activities178.012M66.963M15.528M98.399M5.298M
effect of forex changes on cash-31.00K-145.00K487.00K-541.00K59.00K
net change in cash-58.555M42.04M15.314M-16.211M-93.052M
cash at end of period54.771M113.326M71.286M65.668M81.879M
cash at beginning of period113.326M71.286M55.972M81.879M174.931M
operating cashflow-48.072M-101.513M-78.928M-104.483M-130.475M
capital expenditure-2.569M-1.104M-4.673M-6.251M-2.554M
free cash flow-50.641M-102.617M-83.601M-110.734M-133.029M
Graph

Frequently Asked Questions

How did Blueprint Medicines Corporation do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, BPMC generated $138.16M in revenue last quarter, while its costs came in at $11.21M.

Last quarter, how much Gross Profit did Blueprint Medicines Corporation report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Blueprint Medicines Corporation reported a $126.95M Gross Profit for the quarter ended Jun 30, 2024.

Have BPMC's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. BPMC incurred $169.99M worth of Operating Expenses, while it generated -$43.05M worth of Operating Income.

How much Net Income has BPMC posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Blueprint Medicines Corporation, the company generated -$49.99M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Blueprint Medicines Corporation have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Blueprint Medicines Corporation as of the end of the last quarter was $54.77M.

What are BPMC's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, BPMC had Total Net Receivables of $85.06M.

In terms of Total Assets and Current Assets, where did Blueprint Medicines Corporation stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of BPMC were $903.54M, while the Total Assets stand at $1.20B.

As of the last quarter, how much Total Debt did Blueprint Medicines Corporation have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of BPMC's debt was $740.35M at the end of the last quarter.

What were BPMC's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, BPMC reported total liabilities of $883.32M.

How much did BPMC's Working Capital change over the last quarter?

Working Capital Change for BPMC was -$26.81M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

BPMC generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. BPMC generated -$48.07M of Cash from Operating Activities during its recently reported quarter.

What was BPMC's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. BPMC reported a -$58.56M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph